Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025
Apr 03, 2025 17:00 HKT |  |
|
analytica Vietnam 2025 Opens Tomorrow: The Leading Laboratory Exhibition Returns to Vietnam
Apr 01, 2025 20:01 HKT |  |
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum
Mar 21, 2025 23:00 HKT |  |
|
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease
Mar 16, 2025 01:30 HKT |  |
|
Giftify, Inc. Announces Smart Savings Solution for Popular GLP-1 Diabetes and Weight Loss Medications
Feb 21, 2025 08:00 HKT |  |
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025
Feb 14, 2025 20:00 HKT | |
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10
Jan 24, 2025 23:00 HKT | |
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type
Jan 09, 2025 08:00 HKT | |
|
World's first high-standard negative-pressure isolation ward built with MiC technology completes historical mission
Dec 30, 2024 20:04 HKT | |
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
Dec 09, 2024 13:00 HKT | |
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
Dec 02, 2024 21:30 HKT | |
|
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
Oct 21, 2024 10:00 HKT | |
|
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
Sep 24, 2024 21:00 HKT | |
|
Taiwan Excellence Pavilion concludes Medical Fair Asia 2024 with Showcase of Cutting-Edge MedTech Innovations
Sep 13, 2024 17:50 HKT |  |
|
Taiwan Excellence Unveils Pioneering Medtech Innovation at Medical Fair Asia 2024
Sep 05, 2024 23:00 HKT | |
|
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Aug 23, 2024 08:00 HKT | |
|
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023
Aug 16, 2024 13:00 HKT | |
|
An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparation
Aug 15, 2024 20:00 HKT |  |
|
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China
Aug 05, 2024 22:00 HKT | |
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 20:00 HKT | |
|
|
Next >>
|